CAD 0.05
(-16.67%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 218.03 Thousand USD | 475.58% |
2018 | 37.88 Thousand USD | -20.98% |
2017 | 47.93 Thousand USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 15.32 USD | 145.58% |
2014 | 6.24 USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 9584.76 USD | 175.54% |
2005 | 3478.56 USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 100.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2019 FY | 218.03 Thousand USD | 475.58% |
2019 Q4 | -51.22 Thousand USD | 0.0% |
2019 Q3 | - USD | -100.0% |
2019 Q2 | 4200.00 USD | -98.42% |
2019 Q1 | 265.06 Thousand USD | 148.76% |
2018 Q2 | 201.4 Thousand USD | 0.0% |
2018 FY | 37.88 Thousand USD | -20.98% |
2018 Q4 | -543.6 Thousand USD | -243.02% |
2018 Q3 | 380.08 Thousand USD | 88.72% |
2018 Q1 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 47.93 Thousand USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | 15.32 USD | 145.58% |
2015 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 6.24 USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q1 | 2352.64 USD | 6.17% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | -100.0% |
2007 FY | - USD | -100.0% |
2006 Q3 | 2592.69 USD | 0.0% |
2006 Q1 | - USD | -100.0% |
2006 FY | 9584.76 USD | 175.54% |
2006 Q2 | - USD | 0.0% |
2006 Q4 | 2215.97 USD | -14.53% |
2005 Q4 | 2698.45 USD | 741.11% |
2005 Q3 | 320.82 USD | 0.0% |
2005 FY | 3478.56 USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | NaN% |
Asep Medical Holdings Inc | 21.14 Thousand CAD | 100.0% |
BetterLife Pharma Inc. | - CAD | NaN% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | - CAD | NaN% |
Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 100.0% |
Defence Therapeutics Inc. | - CAD | NaN% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 100.0% |
Gemina Laboratories Ltd. | - CAD | NaN% |
Glow Lifetech Corp. | 43.93 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | - CAD | NaN% |
Pharmala Biotech Holdings Inc. | 532 Thousand CAD | 100.0% |
Doseology Sciences Inc. | 98.52 Thousand CAD | 100.0% |
MYND Life Sciences Inc. | - CAD | NaN% |
Nova Mentis Life Science Corp. | 28.34 Thousand CAD | 100.0% |
PharmaTher Holdings Ltd. | - CAD | NaN% |
PreveCeutical Medical Inc. | - CAD | NaN% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 100.0% |